Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.

Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection. Can J Urol. 2006 Oct; 13(5):3291-5.

View in: PubMed

subject areas

Administration, Intravesical
Aged
Aged, 80 and over
Botulinum Toxins, Type A
Female
Humans
Male
Middle Aged
Neuromuscular Agents
Pilot Projects
Urinary Bladder, Overactive

authors with profiles

Gregory T. Bales